Unichem Labs gets USFDA nod to market generic capsules

The company has received abbreviated new drug application (ANDA) approval to market its Zonisamide capsules, USP 25 mg, 50 mg and 100 mg from the United States Food and Drug Administration (USFDA), Unichem Laboratories said in a BSE filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2YjFNKk
via IFTTT